RUBIUS THERAPEUTICS

Startup

RUBIUS THERAPEUTICS

Description

Rubius Therapeutics develops red cell therapeutics (RCTs) which are engineered red blood cells designed to express biotherapeutic proteins within or on their cell surface to create highly selective, potent and allogeneic cellular medicines in order to treat rare diseases, cancer, and autoimmune diseases.

RUBIUS THERAPEUTICS

Address

United States

Contact

info@rubiustx.com

Description

Rubius Therapeutics develops red cell therapeutics (RCTs) which are engineered red blood cells designed to express biotherapeutic proteins within or on their cell surface to create highly selective, potent and allogeneic cellular medicines in order to treat rare diseases, cancer, and autoimmune diseases.

Matchmaking

Connect with RUBIUS THERAPEUTICS

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL